Minerva Neurosciences Inc reports results for the quarter ended in January - Earnings Summary

Minerva Neurosciences

06/08/2024 14:31

* Minerva Neurosciences Inc  NERV.OQ  reported a quarterly
adjusted loss of $1.09​​ per share for the quarter ended in
January, higher than the same quarter last year, when the
company reported EPS of $-1.12.  The lone analyst forecast for
the quarter was for a loss of 97 cents per share. 
    * Reported revenue was zero​; analysts expected zero. 
    * Minerva Neurosciences Inc's reported EPS for the quarter
was a
loss of $1.09​.
    * The company reported a quarterly loss of $8.23 million.
    * Minerva Neurosciences Inc shares had fallen by 12.2% this
quarter and lost 54.5% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "hold"

Wall Street's median 12-month price target for Minerva
Neurosciences Inc is $7.00 
This summary was machine generated from LSEG data August 6 at
01:31 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.97          -1.09          Missed
 Mar. 31 2024      -1.20          -1.13          Beat
 Dec. 31 2023      -0.88          -1.39          Missed
 Jan. 1 0001       -0.77          -1.03          Missed